Atlas Trials

Dopaminergic Modulation of Brain Activation Using Simultaneous PET/Pharmacological MRI

Clinical trial NCT03326245 · COMPLETED

Trial details

NCT number
NCT03326245
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Normal Physiology
Start date
2018-01-29
Primary completion
2021-12-13
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.